Discover answers to your questions with Westonci.ca, the leading Q&A platform that connects you with knowledgeable experts. Get precise and detailed answers to your questions from a knowledgeable community of experts on our Q&A platform. Join our Q&A platform to connect with experts dedicated to providing accurate answers to your questions in various fields.

Hemorrhagic bladder is an adverse effect associated with the use of cyclophosphamide in patients with lupus nephritis can be reduced by administering which of the following?
A. Folic acid
B. Desferoxamine
C. Febuxostat
D. Mesna
E. Cobalamin